Hofseth BioCare ASA (OSTO:HBCO) Total Stockholders Equity : kr26.9 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Hofseth BioCare ASA Total Stockholders Equity?

Hofseth BioCare ASA's Total Stockholders Equity for the quarter that ended in Mar. 2025 was kr26.9 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Hofseth BioCare ASA's Book Value per Share for the quarter that ended in Mar. 2025 was kr0.07. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Hofseth BioCare ASA's Debt-to-Equity for the quarter that ended in Mar. 2025 was 8.77.

Hofseth BioCare ASA Total Stockholders Equity Historical Data

The historical data trend for Hofseth BioCare ASA's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hofseth BioCare ASA Total Stockholders Equity Chart

Hofseth BioCare ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

264.45

141.06

148.72

41.83

60.05

Hofseth BioCare ASA Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															156.35	138.23	103.76	60.05	26.93

Hofseth BioCare ASA (OSTO:HBCO) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Hofseth BioCare ASA's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(26.932	-	0)	/	395.076
	=	0.07

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Hofseth BioCare ASA's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(73.624	+	162.562)	/	26.932
	=	8.77

Hofseth BioCare ASA Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Hofseth BioCare ASA's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Hofseth BioCare ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Hofseth BioCare ASA (OSTO:HBCO) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

HOFBF:USA HBC:Norway 0Q6H:UK HBQ:Germany

Address

Keiser Wilhelms Gate 24, Aalesund, NOR, 6003

Website

https://www.hofsethbiocare.com

Hofseth BioCare ASA is a Norway-based company engaged in the business of developing, manufacturing, marketing, and selling marine ingredients such as oil, calcium, and protein products. Its products and their respective brands include salmon oil (OmeGo), hydrolyzed soluble protein (ProGo), Calcium/Collagen (CalGo or NT-II), and non-soluble protein (PetGo), all of which are produced in the Midsund plant. The firm sells its products to various segments of the human nutrition market, such as sports nutrition, supplements, and health foods, as well as to the market within nutrition for the pet and feed industry. It generates maximum revenue from the sale of salmon oil. Geographically, the company generates maximum revenue from Europe, followed by North America and Asia.

Hofseth BioCare ASA Headlines

No Headlines